Literature DB >> 3647940

Isolation usage in a pediatric hospital.

M H Kim, C Mindorff, M L Patrick, R Gold, E L Ford-Jones.   

Abstract

In a prospective 12-month study at a university-affiliated pediatric hospital, isolation usage was quantitated by ward/service, season, isolation category and type of infection (community-acquired vs nosocomial). Such information may be helpful in designing hospitals, recognizing time utilization of the pediatric infection control nurse, and defining educational and isolation needs. Hospitals with multiple bed rooms and inadequate numbers of single rooms may be unable to meet current federal isolation guidelines. The mean number of isolation days was 153 per 1000 patient days or 15.3% of bed days used. This ranged from 18.5% on the infant/toddler/preschool medical ward to 2.8% on child/teenage orthopedic surgery. Isolation requirements vary seasonally and rose to 32% in winter on one ward. Proportional frequencies of isolation category included enteric--29%, protective--28%, strict--16%, barrier (contact)--10%, multiply resistant organism (MRO)--8%, wound--5%, pregnant women (careful handwashing)--3%, blood and body fluid precautions--1%. Isolation of patients with and contacts of nosocomial infections account for 32% of isolation usage. During one third of the 365-day year, the hospital is unable to provide adequate numbers of single rooms for one to 20 patients.

Entities:  

Mesh:

Year:  1987        PMID: 3647940     DOI: 10.1017/s0195941700065930

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  3 in total

1.  Reducing the number of missed isolation days in a paediatric high-dependency unit using semi-permanent pods.

Authors:  Josephine Keward; Pauline Bradshaw; Jonathan A Otter
Journal:  J Infect Prev       Date:  2017-02-02

2.  Essentials of paediatric infection control.

Authors:  D L Moore
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

3.  Utilization of paediatric isolation facilities in a TB-endemic setting.

Authors:  Angela Dramowski; Mark F Cotton; Andrew Whitelaw
Journal:  Antimicrob Resist Infect Control       Date:  2015-09-21       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.